HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,191.00
-38.00 (-3.09%)
At close: Apr 2, 2026
HLB bioStep Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 41,157 | 46,174 | 68,799 | 14,873 | 6,158 |
Short-Term Investments | - | 686.98 | 1,578 | 55,000 | - |
Trading Asset Securities | 2,186 | - | - | 27,191 | 4,235 |
Cash & Short-Term Investments | 43,343 | 46,861 | 70,377 | 97,064 | 10,393 |
Cash Growth | -7.51% | -33.41% | -27.49% | 833.97% | -30.30% |
Accounts Receivable | 7,549 | 7,483 | 3,730 | 7,009 | 7,788 |
Other Receivables | 451.02 | 1,035 | 337.14 | 2,738 | 662.43 |
Receivables | 8,361 | 8,900 | 4,469 | 10,065 | 10,153 |
Inventory | 1,491 | 1,511 | 1,551 | 1,650 | 2,920 |
Prepaid Expenses | 47.9 | 132.68 | 249 | 133.97 | 10.39 |
Other Current Assets | 7,363 | 5,073 | 2,767 | 512.37 | 5,520 |
Total Current Assets | 60,606 | 62,478 | 79,413 | 109,426 | 28,996 |
Property, Plant & Equipment | 37,936 | 52,094 | 40,678 | 39,626 | 39,867 |
Long-Term Investments | 37,086 | 37,687 | 44,916 | 12,811 | 15,051 |
Goodwill | 1,542 | 6,490 | 1,049 | 1,049 | 1,253 |
Other Intangible Assets | 2,884 | 3,485 | 750.69 | 811.65 | 722.08 |
Long-Term Deferred Tax Assets | 147.53 | 3,100 | 1,096 | 2,127 | 1,302 |
Other Long-Term Assets | 14,904 | 2,274 | 2,841 | 6,316 | 7,414 |
Total Assets | 155,575 | 168,329 | 171,714 | 172,187 | 94,626 |
Accounts Payable | 1,471 | 1,904 | 1,573 | 2,050 | 1,648 |
Accrued Expenses | 689.75 | 675.07 | 438.93 | 533.51 | 324.38 |
Short-Term Debt | 24,363 | 28,644 | 54,316 | 1,689 | 1,189 |
Current Portion of Long-Term Debt | 3,748 | 3,748 | 3,448 | 3,224 | 3,000 |
Current Portion of Leases | 365.58 | 414.96 | 367.28 | 398.72 | 841.66 |
Current Income Taxes Payable | 7.72 | 3.11 | 19.77 | 352.86 | 1,444 |
Other Current Liabilities | 17,332 | 10,896 | 4,518 | 4,527 | 8,134 |
Total Current Liabilities | 47,978 | 46,285 | 64,682 | 12,775 | 16,582 |
Long-Term Debt | 1,795 | 1,569 | 2,017 | 85,911 | 10,690 |
Long-Term Leases | 493.15 | 320.38 | 487.93 | 418.11 | 583 |
Pension & Post-Retirement Benefits | 1,780 | 1,541 | 310.49 | 126.46 | 259.14 |
Other Long-Term Liabilities | 2,592 | 1,800 | 643.61 | 753.88 | 151.03 |
Total Liabilities | 54,638 | 51,515 | 68,141 | 99,984 | 28,265 |
Common Stock | 8,701 | 8,673 | 7,863 | 7,053 | 765.19 |
Additional Paid-In Capital | 85,993 | 84,861 | 60,104 | 31,827 | 29,661 |
Retained Earnings | 5,364 | 23,265 | 30,727 | 31,366 | 34,476 |
Treasury Stock | -5,201 | -7,332 | -1,422 | - | - |
Comprehensive Income & Other | 1,416 | 2,407 | 4,318 | 30.94 | -315.38 |
Total Common Equity | 96,272 | 111,874 | 101,590 | 70,278 | 64,587 |
Minority Interest | 4,665 | 4,940 | 1,983 | 1,925 | 1,774 |
Shareholders' Equity | 100,937 | 116,814 | 103,573 | 72,202 | 66,361 |
Total Liabilities & Equity | 155,575 | 168,329 | 171,714 | 172,187 | 94,626 |
Total Debt | 30,765 | 34,696 | 60,637 | 91,641 | 16,304 |
Net Cash (Debt) | 12,578 | 12,165 | 9,740 | 5,424 | -5,911 |
Net Cash Growth | 3.40% | 24.90% | 79.57% | - | - |
Net Cash Per Share | 148.59 | 144.88 | 126.96 | 77.48 | -84.46 |
Filing Date Shares Outstanding | 117.97 | 84.2 | 78.13 | 70.53 | 68.87 |
Total Common Shares Outstanding | 117.97 | 84.2 | 78.13 | 70.53 | 68.87 |
Working Capital | 12,628 | 16,193 | 14,731 | 96,651 | 12,414 |
Book Value Per Share | 816.09 | 1328.74 | 1300.35 | 996.42 | 937.86 |
Tangible Book Value | 91,846 | 101,899 | 99,790 | 68,417 | 62,612 |
Tangible Book Value Per Share | 778.57 | 1210.27 | 1277.31 | 970.03 | 909.17 |
Land | 15,541 | 27,576 | 15,253 | 15,253 | 13,417 |
Buildings | 30,246 | 30,985 | 24,974 | 24,280 | 23,327 |
Construction In Progress | 70 | 40 | 989.4 | - | 511.28 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.